ALPS ADVISORS INC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$696,000
-42.8%
51,899
-6.3%
0.01%
-36.4%
Q2 2021$1,216,000
+117.1%
55,417
+14.3%
0.01%
+37.5%
Q3 2020$560,000
-55.2%
48,478
-5.8%
0.01%
-52.9%
Q2 2020$1,249,000
+65.9%
51,480
-24.7%
0.02%
+41.7%
Q1 2020$753,000
-62.4%
68,324
-9.7%
0.01%
-25.0%
Q4 2019$2,001,000
+17.4%
75,692
+1.1%
0.02%
+23.1%
Q3 2019$1,705,000
-29.1%
74,852
-4.5%
0.01%
-27.8%
Q2 2019$2,404,000
+61.2%
78,412
-12.7%
0.02%
+63.6%
Q1 2019$1,491,000
-9.4%
89,816
+4.5%
0.01%
-15.4%
Q4 2018$1,646,000
-46.7%
85,931
+45.4%
0.01%
-35.0%
Q3 2018$3,091,000
+49.8%
59,114
+24.6%
0.02%
+53.8%
Q2 2018$2,063,000
+46.0%
47,458
+24.4%
0.01%
+18.2%
Q1 2018$1,413,000
+126.8%
38,151
+21.5%
0.01%
+175.0%
Q4 2017$623,000
-9.8%
31,409
+13.1%
0.00%
-20.0%
Q3 2017$691,000
+55.6%
27,766
+9.1%
0.01%
+66.7%
Q2 2017$444,00025,4490.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders